KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Change in Account Payables (2016 - 2025)

Evolent Health has reported Change in Account Payables over the past 11 years, most recently at -$14.9 million for Q4 2025.

  • Quarterly results put Change in Account Payables at -$14.9 million for Q4 2025, down 597.39% from a year ago — trailing twelve months through Dec 2025 was $6.6 million (up 56.29% YoY), and the annual figure for FY2025 was $6.6 million, up 56.29%.
  • Change in Account Payables for Q4 2025 was -$14.9 million at Evolent Health, down from $3.3 million in the prior quarter.
  • Over the last five years, Change in Account Payables for EVH hit a ceiling of $16.6 million in Q3 2024 and a floor of -$14.9 million in Q4 2025.
  • Median Change in Account Payables over the past 5 years was $681000.0 (2021), compared with a mean of $1.2 million.
  • Biggest five-year swings in Change in Account Payables: plummeted 3288.97% in 2023 and later skyrocketed 15851.92% in 2024.
  • Evolent Health's Change in Account Payables stood at -$914000.0 in 2021, then skyrocketed by 890.92% to $7.2 million in 2022, then decreased by 18.32% to $5.9 million in 2023, then tumbled by 49.4% to $3.0 million in 2024, then crashed by 597.39% to -$14.9 million in 2025.
  • The last three reported values for Change in Account Payables were -$14.9 million (Q4 2025), $3.3 million (Q3 2025), and $14.9 million (Q2 2025) per Business Quant data.